Related Experiment Video
Updated: Jan 14, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Medical Therapies of Cushing's Disease-Part 2
Yair Schwarz1, Elisabeth Nowak2, Reut Halperin3
1Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Ramat Gan; Dina Recanati School of Medicine, Reichman University, Herzliyya, Israel; Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Abstract:
Cushing's disease (CD) is an endogenous hypercortisolism state caused by an adrenocorticotropic hormone (ACTH) secreting pituitary adenoma. Medical therapy is an important second-line treatment for CD. New pharmacologic agents for the treatment of patients with CD are under development. New possible intervention targets include various receptors and pathways in the corticotroph tumor, the hormone ACTH, and its receptor and enzymes involved in cortisone metabolism. This part of the article will focus on tailoring pharmacologic therapy according to patient specific characteristics, long-term medical therapy and development of new drugs for CD.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Drug Therapy
Antianxiety Medications
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

